CytoSolv
Latest round
- Seed
Last raised
- Feb 2010
Total raised
- $0.5M
Investors
- 1
About CytoSolv
CytoSolv is based in Tiverton, US and is developing proprietary technology to address wound healing, initially targeting diabetic ulcers. Its technology involves a mixture of wound-healing factors derived from porcine choroid plexus (CP), a key component of the blood brain barrier, which naturally secretes a variety of proteins into the cerebrospinal fluid responsible for growth, differentiation, nurturing and maintenance of the healing function.
Who invested in CytoSolv
1 investor across 1 round
See all investors in CytoSolv
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Feb 9, 2010
Amount
$0.5M
Investors
Questions about CytoSolv
Who invested in CytoSolv?
CytoSolv has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CytoSolv raised?
CytoSolv has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did CytoSolv last raise money?
CytoSolv's most recent round on record is a Seed, in Feb 2010.
What does CytoSolv do?
CytoSolv is based in Tiverton, US and is developing proprietary technology to address wound healing, initially targeting diabetic ulcers.
Where is CytoSolv headquartered?
CytoSolv is headquartered in Tiverton, US.
Which VCs invest in companies like CytoSolv?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at CytoSolv's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like CytoSolv? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.